Downregulation of the circadian genes encoding CRY2, PER1, PER2, PER3, CLOCK, REV-ERBβ, ROR-α and ROR-β was associated with significantly higher mortality rates in the glioma cohort, hinting at possible tumor suppressor roles. This evidence concerns the gene PER2 and central nervous system cancer.